Lynk Pharmaceuticals

Company Drug

Lynk Pharma Gets NMPA Green Light for LNK01004 Atopic Dermatitis Study

Fineline Cube Aug 3, 2022

Hangzhou-based Lynk Pharmaceuticals Co., Ltd announced it has received approval from the National Medical Products...

Company Deals

Antengene Corporation Secures $980M Global Licensing Deal with K2 Therapeutics for CDH6×CD3 Bispecific T-Cell Engager

Company Deals

CSPC Innovation Pharmaceutical Files Hong Kong IPO Prospectus Following Strategic Evolution from Caffeine Producer to Biopharmaceutical Player

Company Deals

Zhiyi Biotechnology Files Hong Kong IPO Prospectus as China’s Leading Live Biotherapeutic Products Developer

Company Drug

Gan & Lee Pharmaceuticals Secures UAE Approval for Insulin Glargine Prefilled Pen, Expanding Global Diabetes Portfolio